Trump announces drug pricing deal with AstraZeneca
PositiveU.S News

President Trump has made headlines by announcing a significant drug pricing deal with AstraZeneca, which aligns with his Most Favored Nation policy. This agreement ensures that Medicaid patients will pay prices that are comparable to the lowest rates available in other countries. This move is crucial as it aims to lower drug costs for Americans, making essential medications more accessible and affordable, especially for those relying on Medicaid.
— Curated by the World Pulse Now AI Editorial System